Collymore was set to step down in August after nine years at the helm, during which time Safaricom's share price rose by more than 400%.
In May, Collymore, 61, had said he would stay in his position for an extra year. He was set to step down in August after nine years at the helm, during which time Safaricom’s share price rose by more than 400%. Collymore had travelled to Britain in October 2017 and received treatment for Acute Myeloid Leukemia, and he had since been undergoing treatment for the same condition, the company said.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: